Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(50.0%)
Phase 4
1(25.0%)
Phase 1
1(25.0%)
4Total
Phase 2(2)
Phase 4(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03279263Phase 2Unknown

An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy

Role: collaborator

NCT03552991Phase 4Completed

Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes Mellitus

Role: collaborator

NCT01497704Phase 1Completed

Dose-Escalation and Safety Trial of YN968D1

Role: collaborator

NCT02317796Phase 2Completed

Adult Subjects With Uncontrolled Type 2 Diabetes

Role: collaborator

All 4 trials loaded